We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+13.77%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$6.41B
AUM Growth
-$838M
Cap. Flow
-$1.23B
Cap. Flow %
-19.2%
Top 10 Hldgs %
13.63%
Holding
1,903
New
444
Increased
263
Reduced
318
Closed
672

Top Sells

Rank Stock Value
1
PBR icon
Petrobras
PBR
+$43.9M
2
UAN icon
CVR Partners
UAN
+$26M
3
ZM icon
Zoom
ZM
+$12.1M
4
EQT icon
EQT Corp
EQT
+$12M
5
PING
Ping Identity Holding Corp.
PING
+$6.13M

Sector Composition

Rank Sector Weight
1 Healthcare 2.55%
2 Energy 1.26%
3 Technology 1.15%
4 Consumer Discretionary 0.9%
5 Materials 0.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
U icon
1101
CALL
Unity
U
$13.8B
$143K ﹤0.01%
5,000
-170,400
-97% -$5.34M
HIMX
1102
Himax Technologies
HIMX
$2.19B
$142K ﹤0.01%
22,824
+20,024
+715% +$127K
AMRS
1103
DELISTED
Amyris Inc.
AMRS
$138K ﹤0.01%
90,000
-160,000
-64% -$357K
SHAK icon
1104
Shake Shack
SHAK
$2.53B
$137K ﹤0.01%
+3,300
New +$161K
TLRY icon
1105
CALL
Tilray
TLRY
$618M
$135K ﹤0.01%
5,000
BIOX icon
1106
Bioceres Crop Solutions
BIOX
$23M
$134K ﹤0.01%
11,106
+1,155
+12% +$15K
BBBY
1107
DELISTED
Bed Bath & Beyond Inc
BBBY
$132K ﹤0.01%
52,500
+50,624
+2,699% +$199K
EIGR
1108
CALL
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$132K ﹤0.01%
3,720
+23
+0.6% +$2.76K
RGNX icon
1109
Regenxbio
RGNX
$620M
$132K ﹤0.01%
+5,804
New +$131K
IHS icon
1110
CALL
IHS Holding
IHS
$2.76B
$123K ﹤0.01%
20,000
GDEVW icon
1111
GDEV Inc Warrant
GDEVW
$42.5K
$121K ﹤0.01%
170,635
GRAB icon
1112
CALL
Grab
GRAB
$14.3B
$121K ﹤0.01%
+37,500
New +$107K
BIOX icon
1113
CALL
Bioceres Crop Solutions
BIOX
$23M
$120K ﹤0.01%
+10,000
New +$130K
ETSY icon
1114
CALL
Etsy
ETSY
$7.75B
$120K ﹤0.01%
1,000
-29,000
-97% -$3.32M
TBCH
1115
Turtle Beach Corp
TBCH
$243M
$119K ﹤0.01%
+16,653
New +$130K
IMUX icon
1116
CALL
Immunic
IMUX
$190M
$119K ﹤0.01%
+8,500
New +$232K
CMCSA icon
1117
Comcast
CMCSA
$85B
$118K ﹤0.01%
+3,364
New +$111K
ABUS icon
1118
Arbutus Biopharma
ABUS
$857M
$117K ﹤0.01%
50,000
+16,216
+48% +$38.8K
CYRX icon
1119
CryoPort
CYRX
$761M
$116K ﹤0.01%
6,713
+1,713
+34% +$36.1K
KALV
1120
DELISTED
KalVista Pharmaceuticals
KALV
$116K ﹤0.01%
+17,139
New +$91.8K
BTG icon
1121
B2Gold
BTG
$5B
$114K ﹤0.01%
32,000
+30,216
+1,694% +$100K
PROCW
1122
DELISTED
Procaps Group, S.A. Warrants
PROCW
$113K ﹤0.01%
242,319
NVTA
1123
CALL
DELISTED
Invitae Corporation
NVTA
$112K ﹤0.01%
60,000
AROC icon
1124
Archrock
AROC
$6.27B
$111K ﹤0.01%
12,400
-53,423
-81% -$428K
EDIT icon
1125
Editas Medicine
EDIT
$396M
$111K ﹤0.01%
12,500

Similar funds

Caption Management's Q4 2022 Portfolio in Review

As of Q4 2022, Caption Management held 1,903 positions worth $6.41B, down 12% from $7.25B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Caption Management withdrew a net $1.23B in Q4 2022, closing 672 positions and reducing 318 holdings. Its most notable exit was Petrobras, an estimated $43.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 2.5% of assets, up from 1.5% a quarter earlier, followed by Energy and Technology.

Against the trend, Caption Management opened a new position in PennyMac Mortgage Investment worth $17.9M.

  • Caption Management's largest Q4 2022 buy was PennyMac Mortgage Investment: 1,448,050 shares worth $17.9M.
  • Caption Management added most to State Street SPDR S&P Biotech ETF in Q4 2022, an estimated $13.6M increase.
  • Caption Management's biggest Q4 2022 reduction was EQT Corp, cutting an estimated $12M.
  • Caption Management fully exited Petrobras in Q4 2022, selling an estimated $43.9M.
  • Caption Management's ten largest holdings make up 14% of its $6.41B portfolio in Q4 2022.
  • Caption Management opened 444 new positions and closed 672 in Q4 2022.
  • Caption Management's portfolio value fell 12% quarter-over-quarter to $6.41B.

Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.